Related Experiment Video
Updated: Aug 6, 2026
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Immunotherapy for renal cell carcinoma
A Belldegrun1, R Figlin, J Danella
1Department of Surgery, University of California, Los Angeles School of Medicine.
Immunotherapy shows promise for metastatic renal cell carcinoma, offering a new treatment avenue. Advances in immunology and molecular biology support its potential effectiveness for patients with this cancer.
Area of Science:
- Oncology
- Immunology
Background:
- Metastatic renal cell carcinoma (mRCC) historically has a poor prognosis.
- Immunotherapy is emerging as a potential treatment modality for mRCC.
Purpose of the Study:
- To review the current and emerging role of immunotherapy in managing metastatic renal cell carcinoma.
- To highlight promising therapeutic strategies including cytokine therapy, adoptive immunotherapy, and gene therapy.
Main Methods:
- Review of current literature on immunotherapy for mRCC.
- Analysis of investigational therapeutic approaches.
Main Results:
- Immunotherapy presents a viable alternative treatment for mRCC.
- Cytokine monotherapy, combination therapy, adoptive immunotherapy, and gene therapy show promise.
Conclusions:
- The prognosis for mRCC patients may improve with immunotherapy.
- Ongoing advancements in immunology and molecular biology are expected to enhance immunotherapy efficacy.
More Related Videos
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy